• Home
  • Servier UK
  • Our products
  • Our News
  • Contact us
  • Report a side effect
Author: Soëlie Moreau

Servier signed a definitive agreement to acquire Symphogen

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline

06/04/2020

Rgenta Therapeutics recipient of the Servier’s 2020 LabCentral Golden Ticket

05/05/2020

Health Innovation Coalition Innovation in response to the Covid-19 health crisis

20/03/2020

Cellectis and Servier Expand Collaboration on UCART19 Products

19/02/2020
© 2019 LES LABORATOIRES SERVIER
This site is intended for United Kingdom residents
Servier does not sell its products over the Internet
  • Terms of Use
  • Data Privacy
  • Cookies notice
  • Report a side effect
  • Servier Clinical Trials
M-NO-UK-00444 Date of Preparation January 2021

You are now leaving the Servier UK website

Servier UK is not responsible for content on third party websites. Do you wish to continue?

You are now leaving the Servier UK website

and will be redirected to the Servier International website which may contain information not intended for a UK audience. Do you wish to continue?